The Kidney Cancer Program at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center will be hosting a faculty symposium to celebrate its 10-year anniversary.
Featuring more than 60 speakers and panelists and set to include a wide range of topics from basic science to translational research and clinical trials, the symposium will offer a unique opportunity to learn about transformational discoveries, which have led to, among others, a first-in-class drug now FDA approved. It will also provide an opportunity for networking, learning about program resources, and creating new collaborations.
Topics include groundbreaking discoveries about the genetics of kidney cancer, invasion and metastases, tumor latency, metabolism, and rarer tumor types.
“This is an important milestone for the Kidney Cancer Program, and I cannot think of a better way to celebrate it than with a symposium featuring the many faculty at UTSW whose research and contributions are advancing the care of our patients,” said James Brugarolas, M.D., Ph.D., director of the Kidney Cancer Program.
The symposium, a whole-day event, will take place on Wednesday, March 29. Registration closes March 14 at noon.
The Kidney Cancer Program at UT Southwestern Medical Center is one of only two NCI-designated Specialized Programs of Research Excellence (SPORE) in kidney cancer. Established in 2013, the program has become one of the largest kidney cancer efforts worldwide.
